-
Sector Analysis
![]()
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Acute Myeloid Leukemia (AML) Market Report Overview The acute myeloid leukemia (AML) market in the eight major markets (8MM: the US, France, Germany, Italy, Spain, the UK, Japan, and China) was $2.3 billion in 2022. Steady growth is anticipated at a CAGR of more than 4% throughout the forecast period as the number of AML patients continues to climb and new therapies arrive in the 8MM. The AML market research report offers an overview of AML, including epidemiology, symptoms, diagnosis,...
-
Company Profile
![]()
Grail LLC – Company Profile
Grail LLC (Grail), a subsidiary of Illumina Inc, is a healthcare company that conducts medical research for the development of blood screening tests for the early detection of cancer. The company offers Galleri, an early detection test kit that detects multiple types of cancers. Grail also develops solutions to accelerate cancer diagnoses and blood-based detection for minimal residual disease and other post-diagnostic applications. The company offers clinical studies, cancer tests and clinical support services. Its partners include Clevland Clinic, Dana-Farber,...
Add to Basket -
Company Profile
![]()
Kazia Therapeutics Ltd – Company Profile
Kazia Therapeutics Ltd (Kazia) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. The company’s product pipeline includes paxalisib (formerly GDC-0084) and Cantrixil (TRX-E-002-1). Paxalisib is an inhibitor of PI3K /AKT /mTOR pathway to treat glioblastoma multiforme It is in phase II clinical trials. TRX-E-002-1 (Cantrixil) is a third generation benzopyran molecule that acts against cancer stem cells. Cantrixil is in phase I clinical trials for the treatment of ovarian cancer. The company...
Add to Basket -
Product Insights
![]()
Grail LLC Pipeline Insight and Competitive Landscape, 2023
Grail LLC (Grail), a subsidiary of Illumina Inc, is a healthcare company that conducts medical research for the development of blood screening tests for the early detection of cancer. The company offers Galleri, an early detection test kit that detects multiple types of cancers. Grail also develops solutions to accelerate cancer diagnoses and blood-based detection for minimal residual disease and other post-diagnostic applications. The company offers clinical studies, cancer tests and clinical support services. Its partners include Clevland Clinic, Dana-Farber,...
-
Product Insights
![]()
Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Sterilization equipment is used to kill all the microbes (sterilization) from objects. On the basis of application, sterilization is of three types: physical, chemical and ultraviolet. GlobalData's Medical Devices sector report, “Sterilization Equipment (General Surgery) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Sterilization Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Sterilization Equipment report provides key information and...
-
Product Insights
![]()
Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ovarian Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
![]()
Breast Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Breast Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Sector Analysis
![]()
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.